Search Results - "Alroughani, Raed"
-
1
Family planning is the second most relevant factor for treatment decisions after disease activity – Yes
Published in Multiple sclerosis (01-05-2020)Get full text
Journal Article -
2
Pediatric multiple sclerosis: a review
Published in BMC neurology (09-03-2018)“…Pediatric-onset multiple sclerosis (POMS) prevalence and incidence rates are increasing globally. No disease-modifying therapy are approved for MS pediatric…”
Get full text
Journal Article -
3
miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis
Published in Heliyon (30-06-2024)“…Multiple sclerosis (MS) is a complex, neurodegenerative chronic disorder. Circulating diagnostic biomarkers for MS have remained elusive, and those proposed so…”
Get full text
Journal Article -
4
Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study
Published in Journal of headache and pain (21-08-2021)“…Background Coronavirus disease-19 is caused by the severe acute respiratory syndrome coronavirus 2 Headache is a common symptom during and after Coronavirus…”
Get full text
Journal Article -
5
Neuralgic amyotrophy associated with COVID-19 infection: a case report and review of the literature
Published in Neurological sciences (01-06-2021)Get full text
Journal Article -
6
Replication analysis of variants associated with multiple sclerosis risk
Published in Scientific reports (30-04-2020)“…Multiple Sclerosis (MS) is a complex chronic neurodegenerative disorder resulting from an autoimmune reaction against myelin. So far, many genetic variants…”
Get full text
Journal Article -
7
Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study
Published in BMC neurology (05-07-2023)“…It has been reasoned that stressful life events tend to alter immune function thereby increasing the susceptibility to autoimmune diseases including multiple…”
Get full text
Journal Article -
8
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Published in PloS one (01-11-2016)“…Published natural history data on late-onset of multiple sclerosis are limited. We aimed to assess the risk of attaining EDSS 6.0 among patients with…”
Get full text
Journal Article -
9
A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
Published in BMC neurology (21-02-2020)“…Genetic and environmental factors seem to have etiologic roles in multiple sclerosis (MS). Kuwait is regarded as medium to high risk country for MS. However,…”
Get full text
Journal Article -
10
Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis
Published in Annals of neurology (01-03-2015)“…Objective In patients suffering multiple sclerosis activity despite treatment with interferon β or glatiramer acetate, clinicians often switch therapy to…”
Get full text
Journal Article -
11
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS
Published in PloS one (05-06-2015)“…Multiple Sclerosis is more common in women than men and females have more relapses than men. In a large international cohort we have evaluated the effect of…”
Get full text
Journal Article -
12
Risk factors of white matter hyperintensities in migraine patients
Published in BMC neurology (29-04-2022)“…Migraine frequently is associated with White Matter Hyperintensities (WMHs). We aimed to assess the frequency of WMHs in migraine and to assess their risk…”
Get full text
Journal Article -
13
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study
Published in Journal of neurology, neurosurgery and psychiatry (01-10-2016)“…BackgroundDiscontinuation of injectable disease-modifying therapy (DMT) for multiple sclerosis (MS) after a long period of relapse freedom is frequently…”
Get full text
Journal Article -
14
Correction to: A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
Published in BMC neurology (19-08-2020)“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text
Journal Article -
15
Risk of secondary progressive multiple sclerosis: A longitudinal study
Published in Multiple sclerosis (01-01-2020)“…Background: The risk factors for conversion from relapsing-remitting to secondary progressive multiple sclerosis remain highly contested. Objective: The aim of…”
Get full text
Journal Article -
16
The clinical profile of new-onset optic neuritis in arabs, a tertiary center experience in Kuwait
Published in Heliyon (15-07-2024)“…Optic neuritis is an inflammatory disorder of the optic nerve and is often the initial manifestation of systemic demyelinating diseases such as multiple…”
Get full text
Journal Article -
17
Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis
Published in PloS one (13-02-2017)“…Optical coherence tomography (OCT) with retinal segmentation analysis is a valuable tool in assessing axonal loss and neuro-degeneration in multiple sclerosis…”
Get full text
Journal Article -
18
Prevalence and Burden of Primary Headache Disorders in Kuwaiti Children and Adolescents: A Community Based Study
Published in Frontiers in neurology (30-07-2019)“…Primary headaches are common in the pediatric and adolescent population and can be disabling for them and their families. We aimed to assess the prevalence and…”
Get full text
Journal Article -
19
The Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from Kuwait
Published in PloS one (05-11-2015)“…Vitamin D deficiency is associated with several diseases including multiple sclerosis (MS). Several factors influence vitamin D levels and its optimal…”
Get full text
Journal Article -
20
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry
Published in Multiple sclerosis (01-02-2023)“…Background: Effectiveness of cladribine tablets, an oral disease-modifying treatment (DMT) for multiple sclerosis (MS), was established in clinical trials and…”
Get full text
Journal Article